Insulet's Omnipod 5 system was yet another star. The RADIANT study, the first of its kind, highlighted a direct transition from multiple daily injections to this automated system. The results were staggering—participants gained more than five extra hours daily within their target glucose range. This system, combined with Abbott's FreeStyle Libre 2, proved an elegant solution, fusing cutting-edge monitoring with automated insulin delivery in a synergy that minimised hyperglycaemic peaks without sacrificing safety.